. Features of eye diseases in patients with a history of coronavirus infection
Year: 2021, volume 17 Issue: №2 Pages: 330-336
Heading: Тhematic supplement Article type: Case report
Authors: Kudryavtseva Yu.V., Plotnikova Yu.A., Demakova L.V., Popova L.I., Levanova O.G.
Organization: Kirov State Medical University
Heading: Тhematic supplement Article type: Case report
Authors: Kudryavtseva Yu.V., Plotnikova Yu.A., Demakova L.V., Popova L.I., Levanova O.G.
Organization: Kirov State Medical University
Summary:
Objective: using clinical examples, to analyze the connections and features of the course of ophthalmic pathology in COVID-19 patients. We observed changes on the part of the visual organ in patients who had previously been ill with COVID-19 in various degrees of severity who sought ophthalmological help. The report is illustrated by the most striking clinical examples, on the basis of which we proposed the following mechanisms of the effect of coronavirus infection on the eye tissue: 1) activation and generalization of viral infections of the eyes, in particular herpetic, adenovirus, mollusk contagious; 2) ocular vascular disorders in the form of hemophthalmos, cavernous sinus thrombosis with corresponding ophthalmological manifestations; 3) oculomotor disorders due to neuropathy (we present a case of the development of non-friendly strabismus); 4) aggravation of chronic diseases; 5) visual disorders against the background of asthenic syndrome; 6) side effects from the organ of vision against the background of therapy for COVID-19. Based on the demonstrated examples, it is shown that the functional and organic disorders of the visual organ caused by COVID-19 are quite diverse.
Keywords: COVID-19, lesions of the organ of vision
Bibliography:
1. Peng M, Dai J, Kesavulu SCh, et al. The Role of the Ocular Tissue in SARS-CoV-2 Transmission. Clinical Ophthalmology 2020; 14: 3017-24. Published online 2020 Oct 2.
2. Ulhaq ZS, Soraya GV. The prevalence of ophthalmic manifestations in COVID-19 and the diagnostic value of ocular tissue/fluid. Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258 (6): 1351-2.
3. Loffredo L, Pacella F, Pacella E, et al. Conjunctivitis and COVID-19: A meta-analysis. Journal of Medical Virology 2020; 92 (9): 1413-4.
4. Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitisasthe initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J of Ophthalmology 2020; 55 (4): e125-9.
5. Marinho PM, Marcos AA, Romano AC, et al. Retinal findings in patients with COVID-19. Lancet 2020; 395 (10237): 1610.
6. Illarionova AR, Potapova OM, Kosareva OA, et al. The frequency of retinal changes in patients with COVID-19 disease: an observational study. Sechenov Medical Journal 2020; 11 (2): 40-49.
7. Hong N, Yu W, Xia J, et al. Evaluation of ocular symptoms and tropism of SARS-CoV-2 in patients confirmed with COVID-19. Acta Ophthalmologica 2020; 98 (5): 649-55.
8. Maychuk DYu, Atlas SN, Loshkareva АО. Ocular manifestations of COVID-19 coronavirus infection (clinical observation). Bulletin of Ophthalmology 2020; (4): 118-23.
9. Guan W, Ni Z, Ни Yu, et al. Clinical Characteristics of Coronavirus Decease 2019 in China. The New England Journal of Medicine 2020 Apr 30; 382 (18): 1708-20.
10. Xia J, Tong J, Liu M, et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. Journal of Medical Virology 2020 Jun; 92 (6): 589-94.
11. Zhou Y, Duan C, Zeng Y, et al. Ocular findings and proportion with conjunctival SARS-CoV-2 in COVID-19 patients. Ophthalmology 2020; 127: 982-3.
12. Wu P, Duan F, Luo C, et al. Characteristics of Ocular Findings of Patients with Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmology 2020; 138: 575-8.
13. Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurology 2020; 77: 683-90.
14. Dinkin M, Gao V, Kahan J, et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology 2020; 95 (5): 221-3.
15. Wrapp D, Wang N, Corbett KS, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 2020 Mar 13; 367 (6483): 1260-3.
16. KubanovAA, DeryabinDG.Anewlookatthepathogenesis of COVID-19: the disease is a generalized viral vasculitis, and the resulting damage to the lung tissue is a variant of angiogenic pulmonary edema. Bulletin of the Russian Academy of Medical Sciences 2020; 75 (2): 115-7.
17. Тгоуег ЕА, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain, Behavior, & Immunity 2020; 87: 34-9.
18. Mayi BS, Leibowitz JA, Woods AT, et al. The role of Neuropilin-1 in COVID-19. PLOS Pathogens 2021 Jan; 17 (1): e1009153.
19. Shlyakhto EV, Konradi АО, Arutyunov GP, et al. Guidelines for the diagnosis and treatment of diseases of the circulatory system (CVD) in the context of the COVID-19 pandemic (short version). St. Petersburg, 2020; 36 p.
20. Bertoli F, Veritti D, Danese С, et al. Ocular Findings in COVID-19 Patients: A Review of Direct Manifestations and Indirect Effects on the Eye: Review Article. J of Ophthalmology 2020 Aug 27; 2020: 4827304.
| Attachment | Size |
|---|---|
| 2021_02-1_330-336.pdf | 1003.14 KB |
Русский
English